Screening for Immunogenicity: Immunotherapy Challenges and Predictive Approaches Applied to Therapeutic Proteins 

As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in vitro analysis to assess immunogenic risk of therapeutic proteins.

Please join us April 5th in Lyon to learn about the latest scientific advances  in understanding the mechanisms of T cells and how to use these screening tools to meet the challenges of biomolecule development. Click here to register

We hope to see you there!

 Training organized by:

 

This entry was posted in Events, Featured and tagged , , , , , , , , , , , . Bookmark the permalink.